{"disease":{"id":"pneumococcal-vaccine","name":"pneumococcal vaccine"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04551248","title":"Post-marketing Safety Evaluation of Pneumococcal Vaccines Among Children and Elderly Adults.","phase":"","overall_status":"UNKNOWN","enrollment_count":1000000,"lead_sponsor_name":"Sungkyunkwan University","has_results":false},{"nct_id":"NCT04664569","title":"National Bacterial Meningitis Study","phase":"","overall_status":"RECRUITING","enrollment_count":8230,"lead_sponsor_name":"Association Clinique Thérapeutique Infantile du val de Marne","has_results":false},{"nct_id":"NCT04401488","title":"Paediatric Post Pneumococcal Conjugate Vaccine Nasopharyngeal Carriage Study","phase":"","overall_status":"UNKNOWN","enrollment_count":4000,"lead_sponsor_name":"University Hospital Southampton NHS Foundation Trust","has_results":false},{"nct_id":"NCT04078997","title":"An Evaluation of PCV13 Vaccine Schedules, Comparing Impact of 2+1 vs 3+0 on Pneumococcal Carriage in Blantyre, Malawi","phase":"","overall_status":"COMPLETED","enrollment_count":3507,"lead_sponsor_name":"University of Liverpool","has_results":false},{"nct_id":"NCT05298800","title":"Combined Immunization of COVID-19 Inactivated Vaccine With QIV and PPV23","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":3000,"lead_sponsor_name":"Centers for Disease Control and Prevention, China","has_results":false},{"nct_id":"NCT03098628","title":"Trial of Simplified Pneumococcal Vaccination in Vietnam II","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":2501,"lead_sponsor_name":"Murdoch Childrens Research Institute","has_results":false},{"nct_id":"NCT05721456","title":"Evaluation of the Non-Inferiority of a 12-Valent Pneumococcal Conjugate Vaccine in Healthy Children in Brazil.","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":2400,"lead_sponsor_name":"Maria de Lourdes de Sousa Maia, MD","has_results":false},{"nct_id":"NCT03893448","title":"Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-029)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1720,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT01953510","title":"Trial of Pneumococcal Vaccine Schedules in Ho Chi Minh City, Vietnam","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":1400,"lead_sponsor_name":"Murdoch Childrens Research Institute","has_results":false},{"nct_id":"NCT04664556","title":"Invasive Pneumococcal Disease Study","phase":"","overall_status":"RECRUITING","enrollment_count":1369,"lead_sponsor_name":"Association Clinique Thérapeutique Infantile du val de Marne","has_results":false},{"nct_id":"NCT06151288","title":"Safety, Tolerability, and Immunogenicity Study of a 31-Valent Pneumococcal Conjugate Vaccine (VAX-31) in Adults","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":1015,"lead_sponsor_name":"Vaxcyte, Inc.","has_results":true},{"nct_id":"NCT03574389","title":"A Study Assessing 13-valent Pneumococcal Conjugate Vaccine in Healthy Chinese Infants and Young Children","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":936,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT05266456","title":"Safety, Tolerability, and Immunogenicity Study of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Adults","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":835,"lead_sponsor_name":"Vaxcyte, Inc.","has_results":true},{"nct_id":"NCT05844423","title":"Safety, Tolerability, and Immunogenicity of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Healthy Infants","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":802,"lead_sponsor_name":"Vaxcyte, Inc.","has_results":false},{"nct_id":"NCT06234683","title":"PRomoting Older Adults' Pneumococcal Vaccination Through Education and Learning","phase":"NA","overall_status":"COMPLETED","enrollment_count":720,"lead_sponsor_name":"University of Ottawa","has_results":false},{"nct_id":"NCT06608199","title":"A Phase 3 Study to Evaluate the Immunogenicity and Safety of Minhai's PCV13-DT/TT Vaccine As Compared to Pfizer's PCV13 Vaccine","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Beijing Minhai Biotechnology Co., Ltd","has_results":false},{"nct_id":"NCT06703203","title":"Phase I/II Clinical Trial of 26-valent Pneumococcal Conjugate Vaccine","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":450,"lead_sponsor_name":"Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd","has_results":false},{"nct_id":"NCT00980655","title":"Study to Evaluate 13 Valent Pneumococcal Conjugate Vaccine (13vPnC) Vaccine Followed by 23-valent Pneumococcal Polysaccharide Vaccine (23vPS) Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":251,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT06077656","title":"Dose-Ranging Study to Evaluate a 25-Valent Pneumococcal Conjugate Vaccine","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":220,"lead_sponsor_name":"Inventprise Inc.","has_results":true},{"nct_id":"NCT05297578","title":"Safety, Tolerability, and Immunogenicity Study of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Older Adults","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":207,"lead_sponsor_name":"Vaxcyte, Inc.","has_results":true},{"nct_id":"NCT00688870","title":"Study Evaluating A 13-Valent Pneumococcal Conjugate Vaccine Administered to Infants in Taiwan","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":168,"lead_sponsor_name":"Wyeth is now a wholly owned subsidiary of Pfizer","has_results":true},{"nct_id":"NCT05145101","title":"Pneumococcal Vaccination in Patients With Chronic Lymphocytic Leukaemia","phase":"","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"Hannah Garcia Garrido","has_results":false},{"nct_id":"NCT06136832","title":"Pneumonia Vaccine Education Intervention Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":141,"lead_sponsor_name":"Geisinger Clinic","has_results":false},{"nct_id":"NCT05788510","title":"Pneumococcal Vaccination in Patients with Anti-TNF Alpha Therapy","phase":"","overall_status":"COMPLETED","enrollment_count":106,"lead_sponsor_name":"Hôpital NOVO","has_results":false},{"nct_id":"NCT05721092","title":"Assessment of Knowledge on Pneumococcal Vaccination Among Diabetologists in India","phase":"","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"M.V. Hospital for Diabetes","has_results":false},{"nct_id":"NCT06181656","title":"Serologic Response to Pneumococcal Vaccination Among Esophageal Cancer Patients With High Grade Lymphopenia After Chemoradiation","phase":"","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT06337643","title":"A Study to Evaluate Tolerability, Safety and Immunogenicity of MVX01 Pneumococcal Vaccine","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":75,"lead_sponsor_name":"Matrivax Research and Development Corporation","has_results":false},{"nct_id":"NCT05540028","title":"Study to Evaluate a 25-Valent Pneumococcal Conjugate Vaccine","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":65,"lead_sponsor_name":"Inventprise Inc.","has_results":false},{"nct_id":"NCT06271681","title":"Evaluation of PCV21 Vaccination Among PPSV23-experienced, Immunocompromised Elderly Veterans","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":45,"lead_sponsor_name":"VA Sierra Nevada Health Care System","has_results":false}],"total":29},"guidelines":[],"source":"Drug Landscape verified database"}